lamotrigine has been researched along with Reperfusion Injury in 6 studies
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-two rats, eight rats per group, were randomly assigned to the sham group in which only laparotomy was performed, and to the ischemia, methylprednisolone and lamotrigine groups, where the infrarenal aorta was clamped for thirty minutes to induce spinal cord ischemia-reperfusion injury." | 8.02 | Biochemical, pathological and ultrastructural investigation of whether lamotrigine has neuroprotective efficacy against spinal cord ischemia reperfusion injury. ( Fesli, R; Gokce, A; Gokce, EC; Gürer, B; Kahveci, FO; Kahveci, R; Kısa, Ü; Sargon, MF; Sarı, MF, 2021) |
| "Lamotrigine had neuroprotective effects in a gerbil model of global cerebral ischemia." | 7.69 | Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia. ( Beek, O; Cooper, BR; Dickerson, MC; Norton, R; Wiard, RP, 1995) |
| " Riluzole, Lidocaine and Lamotrigine were given prior to renal ischemia only (IO) or IRI." | 4.12 | Pharmacological prevention of renal ischemia-reperfusion injury in a rat model. ( Deng, Y; Li, RW; Smith, PN; Weiss, S; Yang, YL, 2022) |
| "Thirty-two rats, eight rats per group, were randomly assigned to the sham group in which only laparotomy was performed, and to the ischemia, methylprednisolone and lamotrigine groups, where the infrarenal aorta was clamped for thirty minutes to induce spinal cord ischemia-reperfusion injury." | 4.02 | Biochemical, pathological and ultrastructural investigation of whether lamotrigine has neuroprotective efficacy against spinal cord ischemia reperfusion injury. ( Fesli, R; Gokce, A; Gokce, EC; Gürer, B; Kahveci, FO; Kahveci, R; Kısa, Ü; Sargon, MF; Sarı, MF, 2021) |
| "Lamotrigine had neuroprotective effects in a gerbil model of global cerebral ischemia." | 3.69 | Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia. ( Beek, O; Cooper, BR; Dickerson, MC; Norton, R; Wiard, RP, 1995) |
| "Lamotrigine has neuroprotective effect during HCA." | 1.31 | Lamotrigine plus leukocyte filtration as a neuroprotective strategy in experimental hypothermic circulatory arrest. ( Anttila, V; Biancari, F; Hirvonen, J; Jäntti, V; Juvonen, T; Kiviluoma, KT; Ohtonen, P; Pokela, M; Rimpiläinen, J; Romsi, P; Vainionpää, V, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y | 1 |
| Li, RW | 1 |
| Yang, YL | 1 |
| Weiss, S | 1 |
| Smith, PN | 1 |
| Kahveci, FO | 1 |
| Kahveci, R | 1 |
| Gokce, EC | 1 |
| Gokce, A | 1 |
| Kısa, Ü | 1 |
| Sargon, MF | 1 |
| Fesli, R | 1 |
| Sarı, MF | 1 |
| Gürer, B | 1 |
| Yu, IC | 1 |
| Kuo, PC | 1 |
| Yen, JH | 1 |
| Paraiso, HC | 1 |
| Curfman, ET | 1 |
| Hong-Goka, BC | 1 |
| Sweazey, RD | 1 |
| Chang, FL | 1 |
| Barut, I | 1 |
| Tarhan, OR | 1 |
| Kapucuoglu, N | 1 |
| Sutcu, R | 1 |
| Akdeniz, Y | 1 |
| Wiard, RP | 1 |
| Dickerson, MC | 1 |
| Beek, O | 1 |
| Norton, R | 1 |
| Cooper, BR | 1 |
| Rimpiläinen, J | 1 |
| Romsi, P | 1 |
| Pokela, M | 1 |
| Hirvonen, J | 1 |
| Vainionpää, V | 1 |
| Kiviluoma, KT | 1 |
| Biancari, F | 1 |
| Ohtonen, P | 1 |
| Jäntti, V | 1 |
| Anttila, V | 1 |
| Juvonen, T | 1 |
6 other studies available for lamotrigine and Reperfusion Injury
| Article | Year |
|---|---|
Pharmacological prevention of renal ischemia-reperfusion injury in a rat model.
Topics: Animals; Glutathione; Humans; Ischemia; Kidney; Lamotrigine; Lidocaine; Rats; Reperfusion Injury; Ri | 2022 |
Biochemical, pathological and ultrastructural investigation of whether lamotrigine has neuroprotective efficacy against spinal cord ischemia reperfusion injury.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Lamotrigine; Neuroprotective Agents; Rats; Reperfu | 2021 |
A Combination of Three Repurposed Drugs Administered at Reperfusion as a Promising Therapy for Postischemic Brain Injury.
Topics: Animals; Apoptosis; Brain; Brain Ischemia; Drug Therapy, Combination; Female; Lamotrigine; Lovastati | 2017 |
Lamotrigine reduces intestinal I/R injury in the rat.
Topics: Animals; Anticonvulsants; Intestines; Lamotrigine; Rats; Rats, Wistar; Reperfusion Injury; Triazines | 2007 |
Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia.
Topics: Animals; Anticonvulsants; Arterial Occlusive Diseases; Behavior, Animal; Brain Chemistry; Brain Isch | 1995 |
Lamotrigine plus leukocyte filtration as a neuroprotective strategy in experimental hypothermic circulatory arrest.
Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Disease Models, Animal; Electroencephalography; F | 2002 |